Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate Cancer Patients-Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics.
Fernández-Peralbo MA, Gómez-Gómez E, Calderón-Santiago M, Carrasco-Valiente J, Ruiz-García J, Requena-Tapia MJ, Luque de Castro MD, Priego-Capote F. Fernández-Peralbo MA, et al. Sci Rep. 2016 Dec 2;6:38243. doi: 10.1038/srep38243. Sci Rep. 2016. PMID: 27910903 Free PMC article. Clinical Trial.
Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer.
Gómez-Gómez E, Jiménez-Vacas JM, Carrasco-Valiente J, Herrero-Aguayo V, Blanca-Pedregosa AM, León-González AJ, Valero-Rosa J, Fernández-Rueda JL, González-Serrano T, López-Miranda J, Gahete MD, Castaño JP, Requena-Tapia MJ, Luque RM. Gómez-Gómez E, et al. J Cell Mol Med. 2018 Nov;22(11):5688-5697. doi: 10.1111/jcmm.13845. Epub 2018 Sep 6. J Cell Mol Med. 2018. PMID: 30256519 Free PMC article.
Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL.
Gomez Gomez E, Salamanca Bustos JJ, Carrasco Valiente J, Fernandez Rueda JL, Blanca A, Valero Rosa J, Bravo Arrebola I, Marquez López J, Jimenez Vacas JM, Luque R, Requena Tapia MJ. Gomez Gomez E, et al. BMJ Open. 2019 Nov 12;9(11):e031032. doi: 10.1136/bmjopen-2019-031032. BMJ Open. 2019. PMID: 31722940 Free PMC article.
Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.
Jiménez-Vacas JM, Gómez-Gómez E, Montero-Hidalgo AJ, Herrero-Aguayo V, L-López F, Sánchez-Sánchez R, Guler I, Blanca A, Méndez-Vidal MJ, Carrasco J, Lopez-Miranda J, Requena-Tapia MJ, Castaño JP, Gahete MD, Luque RM. Jiménez-Vacas JM, et al. J Clin Med. 2019 Nov 22;8(12):2056. doi: 10.3390/jcm8122056. J Clin Med. 2019. PMID: 31766715 Free PMC article.
Telomere-based risk models for the early diagnosis of clinically significant prostate cancer.
Rubio Galisteo JM, Fernández L, Gómez Gómez E, de Pedro N, Cano Castiñeira R, Pedregosa AB, Guler I, Carrasco Valiente J, Esteban L, González S, Castelló N, Otero L, García J, Segovia E, Requena Tapia MJ, Najarro P. Rubio Galisteo JM, et al. Prostate Cancer Prostatic Dis. 2021 Mar;24(1):88-95. doi: 10.1038/s41391-020-0232-4. Epub 2020 May 4. Prostate Cancer Prostatic Dis. 2021. PMID: 32367011 Free PMC article.
92 results